Selecta Biosciences, Inc.

NASDAQ:SELB

0.8812 (USD) • At close November 13, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 0.2981.121.1750.3876.5515.2495.93816.79520.7139.27333.99929.93724.42719.66311.0511.9514.646006.65400.0130.010.9030000.0170.0270.0260.1372.931.0482.0172.0882.1341.6071.2361.034
Cost of Revenue 002.5070017.78218.62418.96716.539000000000000000000000000000000
Gross Profit 0018.66806.551-12.533-12.686-2.1724.17139.27333.99929.93724.42719.66311.0511.9514.646006.65400.0130.010.9030000.0170.0270.0260.1372.931.0482.0172.0882.1341.6071.2361.034
Gross Profit Ratio 000.88201-2.388-2.136-0.1290.201111111110010111000111111111111
Reseach & Development Expenses 14.86914.6744.30311.413.00217.78218.62418.96716.53919.18217.68920.31820.95114.46313.00415.09113.9610.7314.72415.1528.10412.1347.35310.25611.88514.40711.13913.6239.50410.99411.04411.0336.02166.6487.2115.4835.3144.972
General & Administrative Expenses 7.248.31511.7126.5626.6146.1055.6956.3245.776.2315.5375.5415.4454.7485.2044.7584.425.6374.0984.0723.694.1144.5135.1464.0564.3624.6745.6714.3774.9033.8755.7572.4952.4182.3812.032.1952.2381.872
Selling & Marketing Expenses 000000000000000000000000000000000000000
SG&A 7.248.31511.7126.5626.6146.1055.6956.3245.776.2315.5375.5415.4454.7485.2044.7584.425.6374.0984.0723.694.1144.5135.1464.0564.3624.6745.6714.3774.9033.8755.7572.4952.4182.3812.032.1952.2381.872
Other Expenses 000000.2450.2550.1750.00100.15400.0090.00600.0260.0050.059-0.0010-0.0030.005-0.069-0.0010.0030.0080-0.136-0.016000.0820.004-0.064-0.0180.024-0.013-0.0370
Operating Expenses 22.10922.98916.01517.96219.61623.88724.31925.29122.30925.41323.22625.85926.39619.21118.20819.84918.3816.36718.82219.22411.79416.24811.86615.40215.94118.76915.81319.29413.88115.89714.91916.798.5168.4189.0299.2417.6787.5526.844
Operating Income -21.811050.0840-13.065-18.638-18.381-8.496-1.59913.8610.7734.078-1.9690.452-7.158-7.898-13.734-16.367-18.822-12.57-11.794-16.235-11.856-14.499-15.941-18.769-15.813-19.277-13.854-15.871-14.782-13.86-7.468-6.401-6.941-7.107-6.071-6.316-5.81
Operating Income Ratio -73.19102.3650-1.994-3.551-3.095-0.506-0.0770.3530.3170.136-0.0810.023-0.648-0.661-2.95600-1.8890-1,248.846-1,185.6-16.056000-1,133.941-513.111-610.423-107.898-4.73-7.126-3.174-3.324-3.33-3.778-5.11-5.619
Total Other Income Expenses Net 37.6970-85.16904.0637.251-3.28214.101-6.615-5.25918.0058.299-0.0974.113-17.439-7.5484.005-7.714-0.798-2.318-0.2-0.159-0.218-0.152-0.06-0.027-0.075-0.267-0.822-0.096-0.352-0.223-0.26-0.522-0.5350.2580.346-0.5510.077
Income Before Tax 15.886-17.71-35.085-24.183-9.002-11.387-21.6635.605-8.2148.60128.77812.377-2.0664.565-24.597-15.446-9.729-24.081-19.62-14.888-11.994-16.394-12.074-14.651-16.001-18.796-15.888-19.544-14.676-15.967-15.134-14.083-7.728-6.923-7.476-6.849-5.725-6.867-5.733
Income Before Tax Ratio 53.309-16.1-1.657-62.488-1.374-2.169-3.6480.334-0.3970.2190.8460.413-0.0850.232-2.226-1.292-2.09400-2.2370-1,261.077-1,207.4-16.225000-1,149.647-543.556-614.115-110.467-4.806-7.374-3.432-3.58-3.209-3.563-5.556-5.544
Income Tax Expense 00-5.1850004.09-0.288-0.321000.13815.828000000000000000.0400000000000
Net Income 15.886-17.71-31.282-24.183-9.002-11.387-25.7535.893-7.8938.60128.77812.239-17.8944.565-24.597-15.446-9.729-24.081-19.62-14.888-11.994-16.394-12.074-14.651-16.001-18.796-15.888-19.544-14.676-15.967-15.134-14.083-7.728-6.923-7.476-6.849-5.725-6.867-5.733
Net Income Ratio 53.309-16.1-1.477-62.488-1.374-2.169-4.3370.351-0.3810.2190.8460.409-0.7330.232-2.226-1.292-2.09400-2.2370-1,261.077-1,207.4-16.225000-1,149.647-543.556-614.115-110.467-4.806-7.374-3.432-3.58-3.209-3.563-5.556-5.544
EPS 0.51-0.11-0.2-0.16-0.058-0.074-0.170.032-0.0520.0580.230.1-0.160.04-0.22-0.14-0.092-0.25-0.21-0.28-0.26-0.37-0.31-0.65-0.71-0.84-0.71-0.88-0.66-0.85-0.82-0.77-0.43-0.4-0.44-0.53-0.44-0.53-0.45
EPS Diluted 0.5-0.11-0.2-0.16-0.058-0.074-0.170.032-0.0520.0580.230.099-0.160.038-0.22-0.14-0.092-0.25-0.21-0.28-0.26-0.37-0.31-0.65-0.71-0.84-0.71-0.88-0.66-0.85-0.82-0.77-0.43-0.4-0.44-0.53-0.44-0.53-0.45
EBITDA -21.8110-40.1260-13.065-18.217-17.92-8.08-1.24813.8611.2784.078-1.6210.763-6.951-7.872-13.595-16.183-18.592-13.809-11.63-16.056-11.744-14.5-15.733-18.346-15.644-19.413-13.689-15.66-14.607-13.778-7.283-6.279-6.781-6.905-5.863-5.901-5.617
EBITDA Ratio -73.1910-1.8950-1.994-3.471-3.018-0.481-0.060.3530.3320.136-0.0660.039-0.629-0.659-2.92600-2.0750-1,235.077-1,174.4-16.058000-1,141.941-507-602.308-106.62-4.702-6.949-3.113-3.248-3.236-3.648-4.774-5.432